Full-Time

Inside Sales Associate

Posted on 4/14/2025

Insulet Corporation

Insulet Corporation

1,001-5,000 employees

Compensation Overview

$24 - $35.25/hr

+ Base Salary + No Bonus + No Equity + No Benefits

Entry, Junior

Denver, CO, USA

Category
Inside Sales
Sales & Account Management
Required Skills
Sales
Customer Service
Data Analysis
Requirements
  • Associate degree
  • 0-1+ years of sales experience and demonstrated success in B2B / B2C or a related field (healthcare, pharmaceuticals, medical device, diabetes, or consumer products)
  • Proficiency with technology (CRM systems, MS Office applications)
Responsibilities
  • Deploy a high level of customer service throughout the patient onboarding process, leading the patient from prescription to activating and registering the customers Omnipod device
  • Track patient progress in the pipeline funnel and actively document actions taken or needed
  • Analyze data insights and trends to effectively prioritize pipeline leads to drive business impact
  • Take ownership in investigating data discrepancies or issues and work to resolve, involving appropriate stakeholders
  • Leverage comprehensive product knowledge to address customer inquiries about Omnipod, highlighting its benefits and providing competitive comparisons
  • Tailor communications that proactively address patient needs by taking a consultative approach to selling to drive patient adoption and support overall business objectives
  • Proactively address challenges or patient concerns using data-driven solutions and identify opportunities to improve patient interactions
  • Collaborate seamlessly with reimbursement and field sales in your territory to ensure patient leads progress after prescription has been fulfilled
  • Effectively manage communications with pharmacy representatives to ensure patients appropriately receive Omnipod and data is accurately aligned across teams
  • Provide support to territory partners (Territory Managers and Clinical Services Managers) for resolving provider or patient issues
  • Continuously seek opportunities for process improvement and provide regular feedback and innovative suggestions to enhance Inside Sales and service operations
  • Drive internal initiatives as identified and assigned by leadership
Desired Qualifications
  • Bachelor’s degree
  • Knowledge and understanding of the managed care industry
  • Experience with Salesforce or other CRM system
  • Knowledge of insulin pumps and continuous glucose monitors

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Acton, Massachusetts

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Insulet raised $444.4M to optimize capital structure and support growth.
  • Omnipod 5's expansion into five European countries boosts international presence.
  • Winning $452M in a trade secrets trial strengthens Insulet's financial position.

What critics are saying

  • Emerging diabetes care companies may challenge Insulet's market share.
  • Technological advancements require continuous R&D investment to stay competitive.
  • Supply chain vulnerabilities in semiconductor components could disrupt production.

What makes Insulet Corporation unique

  • Insulet leads in tubeless insulin pump technology with its Omnipod brand.
  • The Omnipod 5 integrates with Dexcom G7 CGM, enhancing diabetes management.
  • Insulet's multinational RADIANT trial showcases innovation in transitioning from daily injections.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Financial Modeling Prep
Mar 28th, 2025
Insulet Corporation's Financial Efficiency in the Medical Device Industry

Insulet competes with companies like DexCom, Tandem Diabetes Care, and Masimo Corporation in the diabetes care market.

Stock Titan
Mar 18th, 2025
Insulet Secures $450M Through Senior Notes Offering: Key Details on Strategic Debt Refinancing

Insulet raises $444.4M through senior notes to refinance existing convertible debt. Strategic move positions medical device maker for future growth while optimizing capital structure.

Stock Titan
Mar 18th, 2025
From Injections to Innovation - Insulet to Present Results from a Multinational Randomized Trial of Direct Transition from Multiple Daily Injections to Omnipod(R) 5 in Adults and Children with Type 1 Diabetes

Insulet (NASDAQ: PODD) will present results from its multinational RADIANT trial at the 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in March 2025.

Path8 Video
Mar 11th, 2025
Insulet product launch video

This video helped Insulet launch its new iPhone app.

Financial Modeling Prep
Mar 6th, 2025
Ubiquiti Inc. (NYSE:UI) Outshines Peers in Capital Efficiency

Ubiquiti competes with companies like Fair Isaac Corporation, Paylocity Holding Corporation, Monolithic Power Systems, EPAM Systems, and Insulet Corporation.

INACTIVE